We are live on ! Find out more
PCIA

Prime Capital Investment Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 25.54%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
+25.54%
3 Year Est. Return
+71.27%
5 Year Est. Return
+71.75%
10 Year Est. Return
AUM
$6.75B
AUM Growth
-$414M
Cap. Flow
-$554M
Cap. Flow %
-8.21%
Top 10 Hldgs %
27.97%
Holding
1,049
New
37
Increased
148
Reduced
712
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 11.12%
2 Healthcare 4.23%
3 Consumer Discretionary 3.73%
4 Financials 3.5%
5 Industrials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RANI icon
901
Rani Therapeutics
RANI
$90.3M
$52.8K ﹤0.01%
13,882
AMZN icon
902
CALL
Amazon
AMZN
$2.9T
$51.4K ﹤0.01%
+5,000
New +$919K
IDXX icon
903
PUT
Idexx Laboratories
IDXX
$45.2B
$51.3K ﹤0.01%
2,100
TSM icon
904
CALL
TSMC
TSM
$2.23T
$44.1K ﹤0.01%
4,000
+2,300
+135% +$349K
SPWR
905
DELISTED
SunPower Corporation Common Stock
SPWR
$39K ﹤0.01%
13,187
-202
-2% -$551
OTLY
906
Oatly Group
OTLY
$417M
$38.9K ﹤0.01%
2,069
-27
-1% -$574
LILM
907
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$34.1K ﹤0.01%
42,900
-35,221
-45% -$33K
ALDX icon
908
Aldeyra Therapeutics
ALDX
$93.5M
$33.1K ﹤0.01%
10,000
-5
-0% -$20
PSNL icon
909
Personalis
PSNL
$1.49B
$32.4K ﹤0.01%
27,673
-441
-2% -$605
LNZA icon
910
LanzaTech
LNZA
$68M
$27.2K ﹤0.01%
147
-2
-1% -$510
ABEV icon
911
Ambev
ABEV
$43.9B
$26.3K ﹤0.01%
12,824
-2,303
-15% -$5.25K
CRBU icon
912
Caribou Biosciences
CRBU
$167M
$26.3K ﹤0.01%
16,018
-292
-2% -$933
LUMN icon
913
Lumen
LUMN
$6.53B
$22.6K ﹤0.01%
20,552
-28,361
-58% -$36K
HON icon
914
PUT
Honeywell
HON
$73B
$21.5K ﹤0.01%
+2,546
New +$484K
PSNY icon
915
Polestar Automotive Holding UK
PSNY
$1.97B
$14.5K ﹤0.01%
614
-24
-4% -$802
MU icon
916
CALL
Micron Technology
MU
$1.04T
$12.1K ﹤0.01%
+6,000
New +$756K
TMO icon
917
PUT
Thermo Fisher Scientific
TMO
$222B
$11.6K ﹤0.01%
800
EFA icon
918
CALL
iShares MSCI EAFE ETF
EFA
$80.1B
$11.1K ﹤0.01%
+9,100
New +$721K
PNFP icon
919
PUT
Pinnacle Financial Partners Inc
PNFP
$16B
$9.45K ﹤0.01%
4,000
RIVN icon
920
CALL
Rivian
RIVN
$23.1B
$7.09K ﹤0.01%
5,500
-500
-8% -$5.22K
CAUD
921
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$6.21K ﹤0.01%
11,476
QQQ icon
922
PUT
Invesco QQQ Trust
QQQ
$481B
$5.92K ﹤0.01%
1,500
-3,000
-67% -$1.35M
SPY icon
923
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$5.73K ﹤0.01%
1,500
-3,000
-67% -$1.57M
ZOM
924
DELISTED
Zomedica Corp.
ZOM
$5.71K ﹤0.01%
39,088
DNA icon
925
Ginkgo Bioworks
DNA
$499M
$5.03K ﹤0.01%
376
-137
-27% -$4.09K

Similar funds

Prime Capital Investment Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Prime Capital Investment Advisors held 1,049 positions worth $6.75B, down 5.8% from $7.16B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Prime Capital Investment Advisors withdrew a net $554M in Q2 2024, closing 124 positions and reducing 712 holdings. Its most notable exit was PIMCO Dynamic Income Fund, an estimated $2.31M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prime Capital Investment Advisors opened a new position in Avantis US Large Cap Value ETF worth $105M.

  • Prime Capital Investment Advisors's largest Q2 2024 buy was Avantis US Large Cap Value ETF: 1,671,891 shares worth $105M.
  • Prime Capital Investment Advisors added most to Avantis US Small Cap Value ETF in Q2 2024, an estimated $94.7M increase.
  • Prime Capital Investment Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $114M.
  • Prime Capital Investment Advisors fully exited PIMCO Dynamic Income Fund in Q2 2024, selling an estimated $2.31M.
  • Prime Capital Investment Advisors's ten largest holdings make up 28% of its $6.75B portfolio in Q2 2024.
  • Prime Capital Investment Advisors opened 37 new positions and closed 124 in Q2 2024.
  • Prime Capital Investment Advisors's portfolio value fell 5.8% quarter-over-quarter to $6.75B.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.